Immunic Inc (IMUX)
1.25
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Immunic Total Liabilities (Quarterly): 20.58M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.58M |
| December 31, 2023 | 25.37M |
| September 30, 2023 | 18.57M |
| June 30, 2023 | 19.46M |
| March 31, 2023 | 17.65M |
| December 31, 2022 | 14.07M |
| September 30, 2022 | 12.27M |
| June 30, 2022 | 10.81M |
| March 31, 2022 | 11.96M |
| December 31, 2021 | 11.98M |
| September 30, 2021 | 11.29M |
| June 30, 2021 | 15.32M |
| March 31, 2021 | 17.28M |
| December 31, 2020 | 9.076M |
| September 30, 2020 | 8.765M |
| June 30, 2020 | 8.467M |
| March 31, 2020 | 6.804M |
| December 31, 2019 | 7.592M |
| September 30, 2019 | 7.077M |
| June 30, 2019 | 3.163M |
| March 31, 2019 | 1.433M |
| December 31, 2018 | 2.551M |
| September 30, 2018 | 5.736M |
| Date | Value |
|---|---|
| June 30, 2018 | 8.348M |
| March 31, 2018 | 9.713M |
| December 31, 2017 | 10.34M |
| September 30, 2017 | 8.28M |
| June 30, 2017 | 7.338M |
| March 31, 2017 | 6.519M |
| December 31, 2016 | 5.58M |
| September 30, 2016 | 4.713M |
| June 30, 2016 | 4.485M |
| March 31, 2016 | 4.872M |
| December 31, 2015 | 6.756M |
| September 30, 2015 | 8.265M |
| June 30, 2015 | 10.14M |
| March 31, 2015 | 11.15M |
| December 31, 2014 | 10.52M |
| September 30, 2014 | 8.781M |
| June 30, 2014 | 7.853M |
| March 31, 2014 | 113.62M |
| December 31, 2013 | 91.24M |
| September 30, 2013 | 70.86M |
| June 30, 2013 | 69.93M |
| December 31, 2012 | 27.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.163M
Minimum
Jun 2019
25.37M
Maximum
Dec 2023
12.88M
Average
11.97M
Median
Total Liabilities (Quarterly) Benchmarks
| Kymera Therapeutics Inc | 157.05M |
| Insmed Inc | 1.624B |
| SELLAS Life Sciences Group Inc | 14.75M |
| Skye Bioscience Inc | 15.95M |
| Leap Therapeutics Inc | 10.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 104.16M |
| Shareholders Equity (Quarterly) | 83.58M |